Zacks Investment ResearchThu, 30 Apr 2026 14:40:40 GMTWhy GSK (GSK) is a Top Value Stock for the Long-TermGSK-0.09%
Zacks Investment ResearchWed, 29 Apr 2026 15:31:17 GMTGSK Q1 Earnings Beat Estimates, Specialty Medicines Drive Sales GrowthGSK-0.09%
Zacks Investment ResearchWed, 29 Apr 2026 12:10:48 GMTGSK (GSK) Tops Q1 Earnings and Revenue EstimatesGSK-0.09%
Zacks Investment ResearchMon, 27 Apr 2026 15:05:36 GMTKrystal Biotech, Inc. (KRYS) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseGSK-0.09%
Zacks Investment ResearchWed, 22 Apr 2026 15:02:25 GMTGSK (GSK) Earnings Expected to Grow: Should You Buy?GSK-0.09%
Seeking AlphaSun, 19 Apr 2026 11:42:31 GMTGSK: 'Strong Buy' On Mo-Rez Oncology Expansion PotentialGSK-0.09%
Zacks Investment ResearchFri, 10 Apr 2026 14:53:14 GMTWhy GSK (GSK) is a Top Momentum Stock for the Long-TermGSK-0.09%
WSJThu, 09 Apr 2026 19:07:00 GMTGSK withdrew an application of a drug touted by Trump and RFK Jr. as a potential treatment for autism. The drug's label last month was updated so that generic versions of it can be marketed for a rare genetic, neurological condition, but not autism.GSK-0.09%
Zacks Investment ResearchTue, 07 Apr 2026 15:01:29 GMTGSK (GSK) is a Top-Ranked Value Stock: Should You Buy?GSK-0.09%
Seeking AlphaThu, 26 Mar 2026 12:45:55 GMTGSK plc (GSK) Presents at Goldman Sachs 9th Annual Biopharma Innovation Summit TranscriptGSK-0.09%
Zacks Investment ResearchMon, 23 Mar 2026 15:56:40 GMTGSK's Risvutatug Rezetecan Gets Japan Orphan Drug Tag for Lung CancerGSK-0.09%
Zacks Investment ResearchThu, 19 Mar 2026 14:41:25 GMTHere's Why GSK (GSK) is a Strong Value StockGSK-0.09%
Seeking AlphaWed, 18 Mar 2026 12:00:22 GMTGSK Expanding Fast - Oncology, HIV, And Smart AcquisitionsGSK-0.09%
Seeking AlphaWed, 11 Mar 2026 20:22:24 GMTGSK plc (GSK) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptGSK-0.09%
Zacks Investment ResearchTue, 10 Mar 2026 16:41:21 GMTGSK Out-Licenses Rights for Rare Liver Disease Drug to AlfasigmaGSK-0.09%
WSJTue, 10 Mar 2026 15:16:00 GMTFDA Approves Drug Trump Touted for Autism to Treat Other Neurological DisorderGSK-0.09%
ForbesTue, 10 Mar 2026 15:05:10 GMTFDA Approves Leucovorin—But Not For Autism, Even After Trump Admin Officials Touted Drug Last YearGSK-0.09%
WSJMon, 09 Mar 2026 07:39:00 GMTGSK Sells Rights to Drug Candidate to Alfasigma for Up to $690 MillionGSK-0.09%
